APRYL BUTLER: Open Payments
NPI 1962007922 · FRANKFORT, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$961 in 59 payments from 14 companies in 2025. Trend: 2023 $605 · 2024 $933 · 2025 $961
Food & beverage: $929Education: $32
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $431 |
| Vanda Pharmaceuticals Inc. | 10 | $136 |
| Novo Nordisk Inc | 4 | $86 |
| Teva Pharmaceuticals USA, Inc. | 2 | $61 |
| Amgen Inc. | 3 | $44 |
| Janssen Pharmaceuticals, Inc | 2 | $42 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $37 |
| GlaxoSmithKline, LLC. | 1 | $23 |
| Lundbeck LLC | 1 | $20 |
| Lilly USA, LLC | 1 | $19 |
Products named: VRAYLAR, HETLIOZ, QULIPTA, AUSTEDO XR, OTEZLA, SPRAVATO, UBRELVY, XIFAXAN.
Industry payments across KY — which companies pay providers there.
